Ignite Creation Date:
2024-05-05 @ 11:29 PM
Last Modification Date:
2024-10-26 @ 10:34 AM
Study NCT ID:
NCT01342003
Status:
COMPLETED
Last Update Posted:
2011-04-26
First Post:
2011-04-25
Brief Title:
HCV Genotype 1a Shows a Better Virological Response to Antiviral Therapy Than HCV Genotype 1b
Sponsor:
Organization:
Azienda Ospedaliera San Camillo Forlanini
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
SAMPLES_WITH_DNA
Bio Spec Description:
HCVRNA determination was performed quantitatively before the treatment TaqMan Roche Diagnostics The TaqMan value utilized to determine the response was 15 IUml TaqMan method was a standardized method utilized from December 2007 in all the center of the CLEO group HCVRNA value was expressed as log10 IUml
Enrollment Count:
388
Enrollment Type:
ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Cohort |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 14266 |
Who Masked List: